On and molar concentration H2O2, NH3 and phenylpyruvate (PP) addition

On and molar concentration H2O2, NH3 and phenylpyruvate (PP) addition to liquid cultures of Gram?(E. coli and B2599) and Gram+ (MSSA and CNS) bacteria. doi:10.1371/1418741-86-2 buy ��-Sitosterol ��-D-glucoside chemical information journal.pone.0054589.tand the spleens and blood collected. A significant decrease in the number of bacteria present in the spleen was observed in mice who had received the IL4I1-PBS-MSSA suspension compared to mice injected with MSSA in HEK-PBS (Figure 6A). This diminution was accompanied by significantly lower levels of plasma IFNc and a trend towards lower levels of the proinflammatory cytokine IL-6 (Figure 6B). We did not detect significant differences in TNFa and IL-10 concentrations, the level of the latter being identical to ?those measured in the blood of naive mice (Figure S6). As the cytokines were measured 24 h after bacterial injection, this may be due to the kinetics of cytokine production after an acute infection [11]. These results indicate that IL4I1 could protect against bacterial growth in vivo. However, we have previously described IL4I1 as an immunoregulatory enzyme, which inhibits IFNcproduction by lymphocytes [2]. We thus verified that the diminution of the IFNc levels in the sera of mice receiving IL4I1 was not due to a direct effect of the enzyme on IFNcproducing cells. Mice were thus injected with lipopolysaccharide (LPS) along with IL4I1-PBS or HEK-PBS and cytokines were measured in the plasma at 24 h, while splenocytes were analyzed by flow cytometry for IFNc production. Under these conditions, no difference in cytokine levels was observed between the two groups of mice (Figure 6C). The IFNc-producing cells were represented by T lymphocytes and NK cells. In all mice that were analyzed, these cells represented 14.665.1 of all T lymphocytes and 34.367.2 of all NK cells, respectively, regardless of the presence of IL4I1 (representative result in Figure S7). Thus, the diminution of plasma IFNc in mice challenged with bacteria andFigure 4. Rescue from IL4I1-induced bacterial growth inhibition. Bacteria were serially diluted in conditioned medium of THP1 or THP1-IL4I1 cells supplemented with 500 mg/ml Phe, 500 mg/ml Trp or both, 1655472 64 mg/ml glutathione or 15 mM HEPES or the combination of the four reagents. After 24 hours, bacterial growth was monitored at an OD of 595 nm. Data are given as mean 6 SEM from five independent experiments performed in duplicate. **p,0.01, Mann-Whitney test in comparison to growth in THP1-IL4I1 conditioned medium without reagent addition. doi:10.1371/journal.pone.0054589.gIL4I1 Antibacterial PropertiesFigure 5. IL4I1 bactericidal effect. Bacteria were grown 24 hours in serial dilutions of conditioned medium of THP1 or THP1-IL4I1 cells and OD measured. The lowest OD for both conditions was selected (t = 0). New DMEM/F12 containing 1 FCS was added, then bacterial re-growth was measured after 7 and 24 hours and compared between bacteria pre-cultured in THP1 and THP1-IL4I1 conditioned medium. Data are given as mean 6 SEM from five independent experiments performed in duplicate. *p,0.05 and **p,0.01, Mann-Whitney test. doi:10.1371/journal.pone.0054589.gIL4I1 probably reflects the reduced inflammation associated with the control of the infection.DiscussionIn this paper, we demonstrate that the phenylalanine oxidase IL4I1 is a bactericidal enzyme, which acts primarily through the production of toxic levels of H2O2 and NH3. This antibacterial effect was observed on both Gram+ and Gram- bacteria. IL4I1 catalyses the oxidative deaminatio.On and molar concentration H2O2, NH3 and phenylpyruvate (PP) addition to liquid cultures of Gram?(E. coli and B2599) and Gram+ (MSSA and CNS) bacteria. doi:10.1371/journal.pone.0054589.tand the spleens and blood collected. A significant decrease in the number of bacteria present in the spleen was observed in mice who had received the IL4I1-PBS-MSSA suspension compared to mice injected with MSSA in HEK-PBS (Figure 6A). This diminution was accompanied by significantly lower levels of plasma IFNc and a trend towards lower levels of the proinflammatory cytokine IL-6 (Figure 6B). We did not detect significant differences in TNFa and IL-10 concentrations, the level of the latter being identical to ?those measured in the blood of naive mice (Figure S6). As the cytokines were measured 24 h after bacterial injection, this may be due to the kinetics of cytokine production after an acute infection [11]. These results indicate that IL4I1 could protect against bacterial growth in vivo. However, we have previously described IL4I1 as an immunoregulatory enzyme, which inhibits IFNcproduction by lymphocytes [2]. We thus verified that the diminution of the IFNc levels in the sera of mice receiving IL4I1 was not due to a direct effect of the enzyme on IFNcproducing cells. Mice were thus injected with lipopolysaccharide (LPS) along with IL4I1-PBS or HEK-PBS and cytokines were measured in the plasma at 24 h, while splenocytes were analyzed by flow cytometry for IFNc production. Under these conditions, no difference in cytokine levels was observed between the two groups of mice (Figure 6C). The IFNc-producing cells were represented by T lymphocytes and NK cells. In all mice that were analyzed, these cells represented 14.665.1 of all T lymphocytes and 34.367.2 of all NK cells, respectively, regardless of the presence of IL4I1 (representative result in Figure S7). Thus, the diminution of plasma IFNc in mice challenged with bacteria andFigure 4. Rescue from IL4I1-induced bacterial growth inhibition. Bacteria were serially diluted in conditioned medium of THP1 or THP1-IL4I1 cells supplemented with 500 mg/ml Phe, 500 mg/ml Trp or both, 1655472 64 mg/ml glutathione or 15 mM HEPES or the combination of the four reagents. After 24 hours, bacterial growth was monitored at an OD of 595 nm. Data are given as mean 6 SEM from five independent experiments performed in duplicate. **p,0.01, Mann-Whitney test in comparison to growth in THP1-IL4I1 conditioned medium without reagent addition. doi:10.1371/journal.pone.0054589.gIL4I1 Antibacterial PropertiesFigure 5. IL4I1 bactericidal effect. Bacteria were grown 24 hours in serial dilutions of conditioned medium of THP1 or THP1-IL4I1 cells and OD measured. The lowest OD for both conditions was selected (t = 0). New DMEM/F12 containing 1 FCS was added, then bacterial re-growth was measured after 7 and 24 hours and compared between bacteria pre-cultured in THP1 and THP1-IL4I1 conditioned medium. Data are given as mean 6 SEM from five independent experiments performed in duplicate. *p,0.05 and **p,0.01, Mann-Whitney test. doi:10.1371/journal.pone.0054589.gIL4I1 probably reflects the reduced inflammation associated with the control of the infection.DiscussionIn this paper, we demonstrate that the phenylalanine oxidase IL4I1 is a bactericidal enzyme, which acts primarily through the production of toxic levels of H2O2 and NH3. This antibacterial effect was observed on both Gram+ and Gram- bacteria. IL4I1 catalyses the oxidative deaminatio.